Barclays’s Trillium Therapeutics Inc. TRIL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-390,496
| Closed | -$6.86M | – | 4020 |
|
|
2021
Q3 | $6.86M | Buy |
390,496
+378,119
| +3,055% | +$6.64M | ﹤0.01% | 1069 |
|
|
2021
Q2 | $120K | Buy |
12,377
+9,214
| +291% | +$89.3K | ﹤0.01% | 3084 |
|
|
2021
Q1 | $34K | Buy |
3,163
+2,966
| +1,506% | +$31.9K | ﹤0.01% | 3590 |
|
|
2020
Q4 | $3K | Sell |
197
-349,103
| -100% | -$5.32M | ﹤0.01% | 3484 |
|
|
2020
Q3 | $4.96M | Sell |
349,300
-134,939
| -28% | -$1.92M | ﹤0.01% | 981 |
|
|
2020
Q2 | $3.92M | Buy |
484,239
+353,069
| +269% | +$2.86M | ﹤0.01% | 1056 |
|
|
2020
Q1 | $530K | Buy |
+131,170
| New | +$530K | ﹤0.01% | 2090 |
|
|
2018
Q1 | – | Sell |
-10,500
| Closed | -$76K | – | 4477 |
|
|
2017
Q4 | $76K | Buy |
+10,500
| New | +$76K | ﹤0.01% | 3144 |
|